Article

University of Chicago names Seenu Hariprasad University of Chicago chairman of Ophthalmology and Visual Science

Author(s):

A vitreoretinal surgeon, Hariprasad joined the University of Chicago in 2005, and has been serving as interim chairman since 2020.

University of Chicago (Image Credit: AdobeStock/Jacob)

(Image Credit: AdobeStock/Jacob)

The University of Chicago has named Seenu M. Hariprasad, MD, the Shui-Chin Lee Professor of Ophthalmology, chairman of its Department of Ophthalmology and Visual Science, effective July 1, 2023.

Hariprasad has been interim chairman since 2020.

A vitreoretinal surgeon, Hariprasad joined the University of Chicago in 2005. During his career, he has developed a strong track record as a clinician, surgeon, researcher, educator, and leader in his department, according to the university news release, and has become a leading specialist in various vitreoretinal disorders, including macular degeneration, diabetic eye disease, intraocular infection, and retinal vein occlusions.

Seenu M. Hariprasad, MD (Image Credit: University of Chicago)

Seenu M. Hariprasad, MD (Image Credit: University of Chicago)

“He has implemented more effective and efficient sutureless microincisional vitrectomy techniques at the medical center, and his clinical research has contributed to the understanding and use of new medications to combat a wide variety of vitreoretinal disorders,” the university noted in the news release.

According to the university’s news release, Hariprasad has served as an investigator in more than 45 national and international retina clinical trials evaluating various medications, sustained drug-delivery devices, and surgical innovations. His work has led to more than 300 peer-reviewed publications, meeting abstracts and textbook chapters, including Management of Retinal Vein Occlusion: Current Concepts, which is among a small number of textbooks dedicated to this disease.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI's new CEO Malvina Eydelman, MD, outlines her mission and vision for the organization
CIME 2025: Neda Shamie, MD, on expanding options in pharmacological presbyopia management
At CIME 2025, Neda Shamie, MD, answers questions about Demodex blepharitis
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
© 2025 MJH Life Sciences

All rights reserved.